It was found that biometal(II) complexes of monensin are of general composition [M(Mon) 2 (H 2 O) 2 ] (M = Mg, Ca, Mn, Co, Ni, Zn) and consist of a similar structure, where metal(II) ions are placed in a distorted octahedral environment. The isostructural metal(II) compounds generally manifest an enhanced antibacterial activity as compared to non-coordinated monensic acid and it was proposed that the observed effects depend both on the nature of metal(II) cations and on the bacteria strain tested [26] [27] [28] . In our previous investigations we found that Ca(II), Co(II) and Mn(II) complexes of monensic acid significantly decrease the viability and proliferation of cultured drug sensitive human squamous carcinoma cell line A431 and its multidrug resistant clones, being more active in comparison to the non-coordinated MonH [30] . The improved activity of these compounds have prompted us to examine their antitumor effect against some of the most common and invasive human malignancies. Increasing the number and expanding the types of tumor cell lines as experimental models will permit the collection of more adequate information about real antitumor (if any) activity of monensin complexes.
For example, the U.S. National Cancer Institute (NCI) in vitro primary screen protocol consists of a panel of 60 different human tumor cell lines [31] .
In the present paper, we report the results on the influence which monensic acid and its mononuclear complexes with ions of Mg(II), Ca(II), Mn(II), Co(II), Ni(II) and Zn(II) (Scheme 2) render on viability and proliferation of cultured human cell lines established from glioblastoma multiforme, cancers of the breast, lung, liver, uterine cervix and of non-tumor human embryonic cell line.
Experimental procedure

Materials
Commercially available sodium monensin (MonNa) was supplied from Biovet Ltd. (Bulgaria). Metal(II) salts and solvents were purchased from Riedel de Häen AG (Germany). Dulbecco's modified Eagle's medium (D-MEM) and fetal bovine serum were purchased from Gibco-Invitrogen (UK). Dimethyl sulfoxide (DMSO), neutral red (NR), crystal violet (CV), propidium iodide (PI), acridine orange (AO) and trypsin were obtained from AppliChem (Germany); purified agar (Difco) and thiazolyl blue tetrazolium bromide (MTT) were from Sigma-Aldrich Chemie GmbH (Germany). All other chemicals of the highest purity commercially available were purchased from local agents and distributors. All sterile plastic ware was from Orange Scientific (Belgium).
Preparation of mononuclear metal(II) complexes
The synthesis of monensic acid (MonH, C 36 H 62 O 11 ) and its biometal(II) complexes [M(Mon) 2 (H 2 O) 2 ] (M = Mg (1), Ca (2), Mn (3), Co (4), Ni (5), Zn (6)) was performed as described earlier [26] [27] [28] . Monensic acid and complexes 1-6 are sparingly soluble in water and for that reason they were prepared as stock solutions in DMSO at concentration of 1 mg mL -1
. Stock solutions of metal(II) salts with the same concentration were also prepared in DMSO. The series of working solutions of all compounds at concentrations of 0.5, 1, 5, 10 and 25 µg mL -1 was obtained after suitable dilution with D-MEM medium up to 1 mL final volume. The effect of the corresponding amount of DMSO administered (0.05 -2.5%) was also evaluated. The possible effect of combination therapy was assessed testing mixtures containing the corresponding metal(II) salt and monensic acid at stoichiometric molar ratio (1 : 1) at concentrations of 0.7, 2, 7, 15 and 36 µM. streptomycin. The cultures were maintained at 37ºC in a humidified CO 2 incubator. For routine passages adherent cells were detached using a mixture of 0.05% trypsin and 0.02% EDTA. The experiments were performed during the exponential phase of cell growth.
Cytotoxicity assays
The cells were seeded in 96-well flat-bottommed microplates at a concentration of 1×10 4 cells per well. After the cells were grown for 24 h to a subconfluent state (~ 60-70%), the cells from monolayers were washed with phosphate buffered saline (PBS, pH 7.2) and covered with media modified with a solution, containing a different concentration (0.5, 1, 5, 10, 25 μg mL -1 ) of the compounds tested. Each solution was applied into 4 to 6 wells. Samples of cells grown in non-modified medium served as controls. After 24, 48 and 72 h of incubation, the effect of the compounds on cell viability and proliferation was examined by an MTT (thiazolyl blue tetrazolium bromide) test. In some cases neutral red (NR) uptake cytotoxicity and crystal violet (CV) staining assays were also performed.
The MTT colorimetric assay of cell survival was performed as described by Mossman [33] . The method consisted of 3 h incubation with MTT solution (5 mg MTT in 10 mL D-MEM) at 37ºC under 5% carbon dioxide and 95% air, followed by extraction with a mixture of absolute ethanol and DMSO (1:1, vol/vol) to dissolve the blue MTT formazan.
The NR assay was based on the method of Borenfreund and Puerner [34] . To each well containing corresponding cells a medium consisting of NR (50 µg mL -1 , 0.1 mL) was added. The plate was placed in an incubator for 3 h for the uptake of vital dye. Thereafter, the medium with NR was removed and the cells were washed with PBS (0.2 mL well -1 ), followed by the addition of 0.1 mL 1% acetic acid solution containing 50% ethanol to extract the dye from the cells.
The CV assay was based on the method of Saotome et al. [35] . After each well was washed with PBS, the cells were fixed and stained with 0.4% crystal violet solution in methanol for 30 min.
Optical density was measured at 540 nm using an automatic microplate reader (TECAN, Sunrise TM , Austria). Relative cell viability, expressed as a percentage of the untreated control (100% viability), was calculated for each concentration. Concentration-response curves were prepared and the effective cytotoxic concentration of the compounds CC 50 (μM) causing 50% reduction of cell viability was estimated from these curves using Origin 6.1. All data points represent an average of three independent assays.
Double staining with acridine orange (AO) and propidium iodide (PI)
The ability of compounds to induce cytopathological changes was assessed using double staining with acridine orange (AO) and propidium iodide (PI) according to the standard procedures [36] . The cells were grown on cover slips in 6-well plates in the presence of the tested compounds. Non-treated cells served as controls. After 24, 48 and 72 h of incubation, the cover slips were removed and washed with PBS for 2 min. Equal volumes of fluorescent dyes containing AO (10 µg mL -1 in PBS) and PI (10 µg mL -1 in bidestilled water) were added to the cells. Fresh stained cells were placed on a glass slide and examined under fluorescence microscope (Leika DM 500B, Wetzlar, Germany) within 30 min, before the fluorescence started to fade. The degree of apoptosis due to the treatment was observed by double staining where the formation of bright green nucleus with chromatin condensation (dense green areas) and/or of orange nucleus showing condensation of chromatin indicate early or late apoptotic cell death, respectively.
Single cell gel electrophoresis (Comet Assay)
Single cell gel electrophoresis was performed at neutral conditions to detect only DNA double-strand breaks. The cells were mixed with low-gelling agarose (1.4%) and immediately spread onto microscopic slides. After 20 min of gel incubation in a lysis solution (146 mM NaCl, 30 mM EDTA, pH 8; 10 mM Tris-HCl, pH 8; 0.1% N-lauroylsarcozine, pH 9), electrophoresis was conducted for 20 min in TBE buffer at 0.4 V cm -1 . After electrophoresis the slides were subsequently dehydrated for 5 min in 75% and in 96% ethanol, respectively. After drying at room temperature, the slides were stained with SYBR green (Molecular Probes) and the results were visualized under a fluorescent microscope (450/490 nm). Images were acquired with a CCD video camera (SONY).
Colony forming method
Tumor cells (10 3 cells per well) suspended in 0.45% purified agar in D-MEM medium containing different concentrations of the compounds examined (ranging from 0.5 to 25 µg mL -1 ) were layered in 24 well microplates. The presence/absence of colonies was registered using an inverted microscope (Carl Zeiss, Germany) during a period of 16 days. Colony inhibitory concentration (CIC, μM) , at which the compounds tested completely inhibit the ability of tumor cells to grow in semi-solid medium, was determined.
Statistical analysis
All experiments were performed in triplicate. The data are presented as mean ± standard error of the mean. Statistical differences between control and treated groups were assessed using one-way analysis of variance (ANOVA) followed by Dunnett post-hoc test.
Results and discussion
Recently the interest in biological activity of monensin (carboxylic Na + /H + ionophore) has increased as a result of the data concerning its antitumor properties. It has been proposed that activation of the Na + /H + antiporter and the resulting pH changes (intracellular alkalization) play a role in cell proliferation, differentiation and apoptosis [37] [38] [39] [40] [41] [42] [43] . It was reported that monensin causes apoptosis of tumor cell lines established from various malignacies [11] [12] [13] [14] [15] 39] . Our previous studies found that monensic acid and some of its biometal(II) complexes significantly decrease viability and proliferation not only of drug sensitive human skin carcinoma cell line A431, but also of its multidrug resistant clones A431-MDR, A431-MRP and A431-ABCG2 that express the MDR1, MRP1 or ABCG2 gene [30] , respectively. In the present study we demonstrate that monensic acid and its biometal(II) complexes significantly decrease viability and proliferation of cultured cell lines established from some of the most common and aggressive human malignancies such as glioblastoma multiforme (8MGBA) and cancers of the breast (MCF-7), lung (A549), liver (HepG2) and uterine cervix (HeLa). The cytotoxicity of compounds was also tested using non-tumor human embryonic cell line Lep3.
For the evaluation of antitumor properties of metal(II) derivatives of the polyether ionophore, a series of monensin isostructural complexes with biometal(II) ions was prepared. Coordination of the metal ions results in the formation of compounds with a composition [M(Mon) 2 (H 2 O) 2 ], where M = Mg (1), Ca (2), Mn (3), Co (4), Ni (5), Zn (6) (Scheme 2). The complexes consist of one metal(II) ion coordinated with two bidentate acting monensin monoanions and with two water molecules [26] [27] [28] . The effect of the compounds on cell viability and proliferation was studied using two trial groups performing short-term (24-72 h) and long-term (16 days) experiments, respectively.
Short-term experiments
The compounds investigated were applied as solutions in DMSO / D-MEM medium at five concentrations of 0.5, 1, 5, 10 and 25 µg mL -1 for 24, 48 and 72 h. The effective molar concentrations at which the compounds were studied are presented in Table 1 . The usual practice of testing compounds with unknown biological properties involves their evaluation at five 10-fold dilutions, starting from a high of 10 -4 M unless otherwise required [31] . The concentration range selected in the present study was chosen on the basis of literature data as well as on results obtained in our previous investigations. Thus, Park et al. report in series of articles that monensin inhibits human cancer cell growth and induces apoptosis when applied at concentrations of 0.5 µM (acute myelogeneous leukemia cells, lymphoma cells [11, 12] ) and of 3 µM (solid cancer cell lines such as MCF-7, COLO, etc. [13] ). It was found that monensin and its metal complexes express antibacterial activity when administered at micromolar concentrations while the metal(II) salts are ineffective by themselves even applied in the millimolar concentration range [26] [27] [28] .
Several steps were performed to evaluate the effect of monensin and biometal(II) complexes 1-6 on the viability and proliferation of cultured human tumor cell lines. Initially, we studied the influence of complexes 1-4 on cell viability and proliferation of non-small cell lung cancer (A549) and hepatoma (HepG2) cells using MTT test. The activity of compounds against these cell lines expressed as CC 50 (μM) values is presented in Table 2 . Next, we extended the experimental cell models, as well as including the complexes of Ni(II) (5) and Zn(II) (6) in the experiments. The cytotoxicity of the compounds against cultured 8MGBA (glioblastoma multiforme), HeLa (carcinoma of the uterine cervix) and MCF-7 (breast cancer) cell lines was assessed by the MTT test (Table 3) .
The results obtained reveal that all compounds studied decrease the viability and proliferation of the treated tumor cells in a time-and concentrationdependent manner within a micromolar concentration range. As can be seen, MonH and complexes 1-6 affect cultured human cancer cells tested with effective CC 50 concentrations found to be generally less than 5 μM after 72 h treatment. In most cases, the new metal(II) complexes 1-6 possess higher cytotoxicity than noncoordinated monensic acid with A549 and HepG2 cell lines being the most chemosensitive among the human tumor cells treated. It should be mentioned that among all compounds studied the Zn(II) complex 6 is the most active compound against the 8MGBA cell line, while the Ni(II) complex 5 possesses the highest cytotoxicity treating HeLa cells.
From the experimental results it can be concluded that generally the complexation with biometal(II) ions improves the antitumor properties expressed by monensic acid between 2-to 10-fold. On the other hand, the possible toxicity of metal ions incorporated in the corresponding compounds should be also considered. For that reason, the efficiency of metal(II) salts to decrease the viability and proliferation of tumor cells was also evaluated. The experimental results showed that metal(II) salts possess cytotoxicity by themselves only when applied at concentrations much higher than 50 μM. A series of solutions containing the corresponding metal(II) salt and monensic acid simply mixed at molar ratio of 1 : 1 were also tested, as described in Section 2.2. The results obtained showed that the ability of monensic acid to inhibit cell growth is not affected by the presence of the metal(II) salt when applied in concentrations ranging from 0.7 to 36 μM. From the data observed it can be inferred that the increased activity of monensin complexes can not be simply discussed in the terms of the additive effect manifested both by the antibiotic and by the corresponding metal ions administered separately or in combination.
The present assessment of toxicity of monensic acid and complexes 1-6 raised the question whether these compounds could be utilized therapeutically in cancer treatment and control without affecting healthy cells. For that reason the cytotoxic effect of MonH and its complexes was determined using the non-tumor human cell line of embryonic origin Lep 3. Theoretically, for such comparative study, it is best to select primary cultures isolated from the same healthy human tissue as that of the tumor origin (for example brain tumor and normal brain tissue as well as bone marrow cells) as controls. Obviously, this is not easily achieved and for that reason the effect of monensic acid and complexes 1-6 on the viability of human embryonic Lep3 cells was evaluated (Table 4) .
From the results it can be seen that the non-tumor Lep3 cells also possess strong chemosensitivity towards monensic acid and compounds 1-6. This fact is not surprising since the cell line is of non-tumor origin but it is widely accepted that normal embryonic and cancer cells share some common properties such as low differentiation and high proliferation potential. The embryonic cells are very sensitive and any change in their chemical environment could be fatal to their development. On the contrary, once escaped from the immune response and regulation systems of the organism, tumor cells are supposed to fight in different biochemical surroundings and are more suited to survive chemical changes in their environment. The conventional antitumor preparations used in current oncology recognize cancer cells mostly due to their high proliferative activity. Unfortunately some normal cells also have proliferative capacity, as in the case of the Lep3 cell line. The opposite situation is also known -there are tumor cells that do not divide and are therefore "invisible" to the anticancer agents.
Monensin and complexes 1-6 are non-soluble in water and for that reason they were applied as solutions in DMSO / D-MEM medium during the experiments. In this respect an evaluation of the effect of DMSO administered alone (0.05 -2.5%) on viability and proliferation of treated cells was performed, since it is not a natural ingredient of the human body and several systemic side effects derived from its application have been observed [44] . At the same time, DMSO was proved to be a topical analgetic, a hydroxyl radical scavenger, an antidote to the extravasation of vesicant anticancer drugs and a cell-differentiation agent. This compound is one of the most common solvents used for in vivo administration of water-insoluble substances [45] . In relation to the present study, the experimental data have shown that in most cases the effective cytotoxic concentrations (CC 50 ) of MonH and 1-6 are less than 5 μM (especially for the 48-72 h study), a value which corresponds to concentration of the active compound c.a. 3.5 μg mL -1 in the case of MonH and c.a. 7 μg mL -1 in the case of compounds 1-6. The simple calculations reveal that the amount of DMSO in these solutions is only 0.35% and 0.70%, respectively, and it was found that applied in such concentrations, its cytotoxicity is negligible compared to the effects manifested by MonH and complexes 1-6. The anticancer activity of monensic acid and 1-6 can be assessed by several methods, varying in cell targets and in the corresponding mechanisms by which the compounds accomplish their effect. In the present study, three separate assays (MTT, NR and CV) were simultaneously performed using the cultured human tumor cell line 8MGBA under the same conditions (Fig. 1) . The MTT test is based on the ability of viable mitochondria within cells to reduce succinic dehydrogenase; the basic NR dye distributes to the acidic compartments in the cell and therefore acts as a marker for the integrity of lysosomes and possibly of the Golgi apparatus; and the CV staining shows the growth rate reduction reflected by the colorimetric determination of the stained cells. The experimental results revealed that a positive correlation between the data obtained by these three methods was observed after 72 h treatment.
The differences noted could be explained by the different mechanisms and cell targets on which these methods are based. The enhanced activity of monensin biometal(II) complexes provoked our interest to determine if MonH and 1-6 could cause cytopathological changes in tumor cells. In these experiments HeLa cells were tested using double staining with AO and PI (Fig. 2) . It can be seen that significant cell losses are observed in HeLa cells treated with all compounds while the available cells are swollen with picnotic nuclei and chromatin condensation (Fig. 2a) . Additionally, upon treatment with MonH and 1-6 several phenomena were established as follows: i) consolidated lysosomal granules located perinucleary and throughout the cytoplasm in case of MonH (Fig. 2b) and Mg(II) complex 2 (Fig. 2d) , ii) fusion of lysosomes and vacuolation of the cytoplasm (Mg(II) complex 2 (Fig. 2d) , Ni(II) complex 5 (Fig. 2g) ), iii) foamy vacuolation of the cytoplasm after treatment with Ca(II) complex 1 (Fig. 2c) ; iv) lysosomal losses, vacuolation of the cytoplasm, and significant expansion of lysosomal accumulations (Mn(II) complex 3 (Fig. 2e) , Co(II) complex 4 (Fig. 2f) , Zn(II) complex 6 (Fig. 2h) ). According to the cytopathological features observed following double fluorophore (AO/PI) staining, it could be supposed that the programmed cell death (apoptosis) plays the major role during the severe toxic effect induced by monensin and its metal(II) complexes.
The cytopathological changes observed in HeLa cells after treatment with MonH and compounds 1-6 posed the question whether these substances are also able to induce double stranded DNA damages in the treated cells. The results on single cell gel electrophoresis (Comet assay) at neutral pH (Table 5) showed that applied at concentrations of 7 μM for 72 h, monensic acid and its biometal(II) complexes induce double stranded DNA damages with complexes 1 and 5 being the most active (84%) as compared to the non-coordinated antibiotic (67%).
Long-term experiments
The MTT, NR, CV, AO/PI and Comet assays demonstrate the "quick" (24 -72 h) effect of the compounds on monolayer (2D) cell cultures, whereas the colonyforming assay reveals their long-term ability to suppress the growth of tumor cell colonies (3D) in a semi-solid medium. Such 3D tumor cell systems better resemble the in vivo behaviour of neoplastic formations and it is widely accepted that common 2D cell cultures do not adequately represent the functions of 3D tissues that have extensive cell-cell and cell-matrix interactions, as well as markedly different diffusion/transport conditions [46, 47] . The results on evaluation of the influence of MonH and 1-6 on 3D colony-formation in a semi-solid medium (A549, 8MGBA and HeLa cells) are presented in Table 6 . The data are expressed as the effective colony inhibitory concentration (CIC, μM) -the lowest concentration at which the compounds completely inhibit the tumor cell growth. According to their capacity to inhibit both the viability/proliferation and the colony-forming ability of the treated tumor cells, the compounds examined are graded in hierarchic orders that are presented in Table 7 . As can be seen, a good correlation between these two groups of methods (short term and long term experiments, respectively) was observed in our studies. It should be noted that the complexes of Ca(II) (2), Mn(II) (3) and Co(II) (4) show the highest cytotoxicity against the cell line A549, established from the cancer of the lung, while the complexes of Ni(II) (5) and Zn(II) (6) are the most effective compounds for treating HeLa cells isolated from the cancer of the uterine cervix.
The data obtained in our study reveal that MonH and its biometal(II) complexes express promising cytotoxic and/or cytostatic properties against cell lines established from glioblastoma multiforme and cancers of the lung, liver, breast and uterine cervix. These results are not surprising and could be explained at least partially by the ability of monensin to induce significant alterations in the treated cells such as changes in pH level and ATP content; early mitochondrial damage and energy deficit; cell cycle arrest (in G1/G1-M phase) and apoptosis (associated with changes in Bax, caspase-3, caspase-8 and mitochondrial transmembrane potential) and/or necrosis [11] [12] [13] [14] [15] 48] . Additional experiments are underway to better characterize the cellular and molecular mechanism(s) of action of the tested compounds.
A question that provokes interest and has to be discussed here, is whether (and how) the presence of the biometal(II) ion influences the cytotoxic and cytostatic properties of non-coordinated monensic acid. As found in our previous investigations, the isostructural metal(II) compounds possess generally enhanced activity against Gram-positive aerobic and anaerobic bacteria [26] [27] [28] and exert more pronounced antitumor activity against drug sensitive (parental) and multidrug resistant cultured human skin cancer cell lines [30] in comparison to MonH. The results shown in the present study also indicate that complexes 1-6 express stronger cytotoxic and antiproliferative effects against human tumor cells than monensic acid. At the same time, compounds 1-6 show more pronounced antitumor properties than the corresponding metal(II) salts. A cell specific response was observed in the present investigations. Thus, the complexes of Ni(II) (5) and Zn(II) (6) were found to exhibit the highest cytotoxic and cytostatic activity against glioblastoma (8MGBA) and cervical carcinoma (HeLa) cells, whereas the Co(II) complex of MonH (4) demonstrates the highest effectivity in breast cancer cells (MCF-7).
The existence of some variations in antineoplastic properties of the compounds that share a very similar chemical structure could be explained by at least two reasons: i) the influence of the metal(II) ions -Mg(II), Ca(II), Mn(II), Co(II), Ni(II) and Zn(II) are known to play different roles in biological systems, and ii) the cell specific response -the cell lines used as experimental models in investigations performed are established from different hystologic types of tumors. Something more, due to so called tumor heterogenity phenomenon, each tumor/tumor cell line can differ in biological characteristics and behavior compared to the other tumors/tumor cell lines of the same type [49] . 
Conclusions
In summary, the present study demonstrates that monensic acid (MonH) and its biometal(II) complexes [M(Mon) 2 (H 2 O) 2 ] (M = Mg, Ca, Mn, Co, Ni, Zn) exert promising cytotoxic and antiproliferative properties against human tumor cell lines established from glioblastoma multiforme (8MGBA) and cancers of the lung (A549), breast (MCF-7), uterine cervix (HeLa) and liver (HepG2). The human non-tumor cell line Lep3 also expresses strong chemosensitivity, probably due to its embryonic origin. The data obtained merit further investigations to better clarify the cellular targets, mechanism(s) of action and biological safety of these compounds. The knowledge concerning the relationship between the chemical structure of such compounds and their biological activities will facilitate the design of drugs with improved anticancer properties.
